31 related articles for article (PubMed ID: 9043762)
1. The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.
Dwyer-Nield L; Hickey GA; Friedman M; Choo K; McArthur DG; Tennis MA; New ML; Geraci M; Keith RL
Cancer Prev Res (Phila); 2017 Nov; 10(11):671-679. PubMed ID: 28851689
[TBL] [Abstract][Full Text] [Related]
2. Oral iloprost improves endobronchial dysplasia in former smokers.
Keith RL; Blatchford PJ; Kittelson J; Minna JD; Kelly K; Massion PP; Franklin WA; Mao J; Wilson DO; Merrick DT; Hirsch FR; Kennedy TC; Bunn PA; Geraci MW; Miller YE
Cancer Prev Res (Phila); 2011 Jun; 4(6):793-802. PubMed ID: 21636546
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.
Nemenoff R; Meyer AM; Hudish TM; Mozer AB; Snee A; Narumiya S; Stearman RS; Winn RA; Weiser-Evans M; Geraci MW; Keith RL
Cancer Prev Res (Phila); 2008 Oct; 1(5):349-56. PubMed ID: 19138979
[TBL] [Abstract][Full Text] [Related]
4. Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer.
Nemenoff RA; Weiser-Evans M; Winn RA
PPAR Res; 2008; 2008():156875. PubMed ID: 18509496
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin and its analogues: antimetastatic effects and mechanisms of action.
Schneider MR; Tang DG; Schirner M; Honn KV
Cancer Metastasis Rev; 1994 Dec; 13(3-4):349-64. PubMed ID: 7712596
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostacyclin analogues in in vivo tumor models.
Schneider MR; Schillinger E; Schirner M; Skuballa W; Stürzebecher S; Witt W
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():901-8. PubMed ID: 1705084
[TBL] [Abstract][Full Text] [Related]
7. Rodent model of systemic mammary tumor disease by surgical removal of the spontaneously metastasizing SMT2A mammary carcinoma: inhibitory effect of the stable prostacyclin analogue cicaprost on occult metastasis.
Schirner M; Schneider MR
Int J Cancer; 1995 Jul; 62(2):205-9. PubMed ID: 7622297
[TBL] [Abstract][Full Text] [Related]
8. The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma.
Schirner M; Schneider MR
J Cancer Res Clin Oncol; 1992; 118(7):497-501. PubMed ID: 1624541
[TBL] [Abstract][Full Text] [Related]
9. The stable prostacyclin analogue Cicaprost inhibits metastasis to lungs and lymph nodes in the 13762NF MTLn3 rat mammary carcinoma.
Schirner M; Lichtner RB; Schneider MR
Clin Exp Metastasis; 1994 Jan; 12(1):24-30. PubMed ID: 8287616
[TBL] [Abstract][Full Text] [Related]
10. Tumor metastasis inhibition with the prostacyclin analogue cicaprost depends on discontinuous plasma peak levels.
Schirner M; Kraus C; Lichtner RB; Schneider MR; Hildebrand M
Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):311-7. PubMed ID: 9654405
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
Schirner M; Schneider MR
Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
[TBL] [Abstract][Full Text] [Related]
12. Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumors.
Schneider MR; Schirner M; Lichtner RB; Graf H
Breast Cancer Res Treat; 1996; 38(1):133-41. PubMed ID: 8825130
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
